Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 4 hours ago
Quick guide for EMA experts: registration, declaration of interests and contracts
about 4 hours ago
Quick guide for EMA experts: registration, declaration of interests and contracts
Human medicines European public assessment report (EPAR): Ranivisio, ranibizumab, Date of authorisation: 25/08/2022, Revision: 8, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Ranivisio, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 9, Status: Authorised
about 4 hours ago
Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation...
Agenda of the PRAC meeting 31 August - 3 September 2026
about 4 hours ago
Agenda of the PRAC meeting 31 August - 3 September 2026
Record of data processing activity the 360° assessment (public)
about 5 hours ago
Record of data processing activity the 360° assessment (public)
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation: 17/09/2025, Revision: 2, Status: Authorised
about 5 hours ago
Human medicines European public assessment report (EPAR): Usrenty, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Enurev Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 12, Status: Withdrawn
about 6 hours ago
Human medicines European public assessment report (EPAR): Enurev Breezhaler, glycopyrronium bromide, Date...
Human medicines European public assessment report (EPAR): Daybu, trofinetide, Date of authorisation: 20/08/2026, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Daybu, trofinetide, Date of authorisation...
Guidance for industry on implementing Shortage Prevention Plans (SPP)
about 9 hours ago
Guidance for industry on implementing Shortage Prevention Plans (SPP)
Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban, Date of authorisation: 21/11/2025, Revision: 1, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Svariya (previously Rivaroxaban Koanaa), rivaroxaban...
List of centrally authorised products with safety-related changes to the product information
about 11 hours ago
List of centrally authorised products with safety-related changes to the product information